Category: expert opinion on pharmacotherapy

A “small portion of this otherwise reliable published article contains clinically inaccurate data”

exp opinionA rheumatology researcher in France is retracting a paper for errors in several sentences.

Here’s the retraction notice for “Odanacatib for the treatment of postmenopausal osteoporosis, a paper originally published in October in Expert Opinion on Pharmacotherapy:

Unfortunately, due to an honest error from the author, a small portion of this otherwise reliable published article contains clinically inaccurate data. The publisher and author agree to retract the paper pending correction.

The author of the paper, Roland Chapurlat, tells us: Continue reading A “small portion of this otherwise reliable published article contains clinically inaccurate data”

Plagiarism topples paper co-authored by top tamoxifen scientist

Expert Opinion on Pharmacotherapy has retracted a 2011 paper for plagiarism by two authors, one of whom, V. Craig Jordan, is a leading researcher on the class of drugs known as selective estrogen receptor modulators, or SERMs, and is credited with discovering the anti-tumor properties of the breast cancer drug tamoxifen.

Jordan, who is scientific director at the Lombardi Comprehensive Cancer Center at Georgetown University, appears to have been unaware of the offense when the paper was published. Here’s the notice: Continue reading Plagiarism topples paper co-authored by top tamoxifen scientist